Close
Private equity finds a footing but still searching for momentum as two-year slump bottoms out--Bain & Company's PE Midyear Report Jun 3, 2024 12:01AM
  • Global PE looks to have arrested its freefall as the slide in dealmaking and exits levels off
  • Buyout deal numbers set to stay flat vs 2023 with higher average deal size driving a rise in deal value
  • Multiple challenges facing the sector put the premium for PE firms on adjusting to a new normal

BOSTON, June 3, 2024 /PRNewswire/ --The two-year long slump in global private equity looks finally to be bottoming out, with the industry finding a footing from which to climb... (continue reading...)


Triumph Motorcycle Dealers Ranked First in Industry Study for Providing Quick and Easy Service Appointments Jun 3, 2024 12:01AM
  • Industrywide 1 in 7 Powersports Customers Failed in their Attempt to Schedule Service

MONTEREY, Calif.--(BUSINESS WIRE)-- Triumph was ranked first of 27 powersports brands in Pied Piper’s 2024 PSI® Service Telephone Effectiveness® (STE®) Study, which measured the efficiency and quality of service telephone calls from a customer’s objective of quickly and easily setting up a service appointment. Following the Triumph dealers in the rankings were dealers... (continue reading...)


Sigma 28-45mm F1.8 Full Frame DG DN Art Lens Announced; YouTube Video First Look, Learn More Info at B&H Photo Video Jun 3, 2024 12:00AM

Photography News: Sigma has released a fast full-frame zoom offering a versatile focal length range, a bright f/1.8 design, and optical performance that rivals a prime.

NEW YORK, June 3, 2024 /PRNewswire/ -- B&H is pleased to share the new Sigma 28-45mm f/1.8 DG DN Art lens—a unique full-frame zoom that features a constant f/1.8 maximum aperture and a short wide-angle to normal-length zoom range. This lens is effectively the full-frame mirrorless successor to their... (continue reading...)


ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests Jun 3, 2024 12:00AM

SALT LAKE CITY, June 3, 2024 /PRNewswire/ -- ARUP Laboratories is backing a federal lawsuit filed by the American Clinical Laboratory Association (ACLA) challenging the FDA's final rule to regulate laboratory-developed tests (LDTs) as medical devices. The lawsuit states that the FDA does not have legal authority over medical testing services from Congress and asserts that regulating these services is unreasonable.

... (continue reading...)


10 Fitness Guarantees Uninterrupted Gym Access with SARA, Even After Hours Jun 3, 2024 12:00AM

LITTLE ROCK, Ark., June 3, 2024 /PRNewswire/ -- 10 Fitness announces its commitment to uninterrupted access for members around the clock with its innovative SARA system, making sure the fitness journey never hits a pause.

While most non-staffed gyms leave members stranded outside if access issues arise during unstaffed hours, 10 Fitness stands apart. Thanks to SARA (Secured Access and Revenue Automation), members enjoy seamless entry to... (continue reading...)


More Press Releases

View Older Stories

Jun 3, 2024 12:00AM IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth
Jun 3, 2024 12:00AM BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage
Jun 2, 2024 11:35PM MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest
Jun 2, 2024 11:30PM The9 Signed a Definitive Share Purchase Agreement to Invest in AI-Powered Educational Technology Company
Jun 2, 2024 09:16PM TOYOTA GAZOO Racing and Ogier denied in dramatic finish
Jun 2, 2024 11:01PM AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
Jun 2, 2024 11:00PM AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap
Jun 2, 2024 10:59PM AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024
Jun 2, 2024 10:57PM Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Ann
Jun 2, 2024 10:51PM Appointment of Director to Woodside Board
Jun 2, 2024 10:28PM NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERS
Jun 2, 2024 09:02PM Fujitsu Japan and Juntendo University launch joint research for disaster-resilient, digital medical system
Jun 2, 2024 10:15PM 2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
Jun 2, 2024 10:13PM Flash News: OKX Launches 100% Fee Rebate Campaign
Jun 2, 2024 10:00PM Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
Jun 2, 2024 10:00PM LaVie Care Centers Takes Strategic Actions to Position the Company for Long-Term Success Amidst Challenging Skilled Nursing Operating Environment
Jun 2, 2024 09:41PM Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme
Jun 2, 2024 09:30PM Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer a
Jun 2, 2024 09:25PM SATO Technologies Corp. Reports Limited Incident at the Building Hosting Data Center One
Jun 2, 2024 09:19PM China Medical University Hospital (CMUH, Taiwan) Signs MOU with Malaysian International Medical University
Jun 2, 2024 09:14PM Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
Jun 2, 2024 09:00PM TECNO exhibits its diverse smartphone and AIoT ecosystem with futuristic AR and AI products at COMPUTEX Taipei 2024, with the concept "Smart of Creation"
Jun 2, 2024 09:00PM MSI Unveils New AI and Computing Platforms with 4th Gen AMD EPYC™ Processors at Computex 2024
Jun 2, 2024 09:00PM Nissan Demonstrates Autonomous-Drive Mobility Services Progress on Public Roads
Jun 2, 2024 08:38PM Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
Jun 2, 2024 08:35PM WEBTOON Entertainment Announces Public Filing of Registration Statement for Proposed Initial Public Offering
Jun 2, 2024 08:23PM Mesoblast Corporate Presentation at Investor Conference
Jun 2, 2024 08:00PM HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
Jun 2, 2024 07:00PM Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 2, 2024 07:00PM Other World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock
Jun 2, 2024 06:43PM Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
Jun 2, 2024 06:15PM Fast Guard Service Shares Their Experience with Local Business Owner as the Best Security Guard Company in California
Jun 2, 2024 06:01PM One in Five European Companies Are Facing Strong Pressure to Transform to Stay Viable
Jun 2, 2024 06:00PM New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse
Jun 2, 2024 05:30PM Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
Jun 2, 2024 05:07PM Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Jun 2, 2024 04:00PM FrogData Unveils Major AI Factory Upgrade to Revolutionize Automotive Retail Operations
Jun 2, 2024 03:45PM izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement
Jun 2, 2024 03:30PM Summer Ready with Ulike Air 10: Your Smoothness Companion
Jun 2, 2024 04:07PM When Solar PV Meets Blockchain: Pse.USDT Leading the Green Energy Revolution
Jun 2, 2024 02:32PM TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
Jun 2, 2024 12:40PM GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
Jun 2, 2024 12:30PM Miami Beach Inspires this Summer with Film, Fashion and Music Experiences
Jun 2, 2024 12:30PM CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated
Jun 2, 2024 12:30PM Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
Jun 2, 2024 11:32AM Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479
Jun 2, 2024 11:31AM KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Jun 2, 2024 11:31AM KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Jun 2, 2024 11:27AM Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
Jun 2, 2024 11:27AM Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
View Older Stories